Page last updated: 2024-09-05
l 694,458 and zithromax
l 694,458 has been researched along with zithromax in 2 studies
Compound Research Comparison
Studies (l 694,458) | Trials (l 694,458) | Recent Studies (post-2010) (l 694,458) | Studies (zithromax) | Trials (zithromax) | Recent Studies (post-2010) (zithromax) |
---|---|---|---|---|---|
29 | 0 | 10 | 6,964 | 1,263 | 3,790 |
Protein Interaction Comparison
Protein | Taxonomy | l 694,458 (IC50) | zithromax (IC50) |
---|---|---|---|
30S ribosomal protein S6 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S7 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L15 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L10 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L11 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L7/L12 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L19 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L1 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L20 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L27 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L28 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L29 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L31 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L31 type B | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L32 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L33 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L34 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L35 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L36 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S10 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S11 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S12 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S13 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S16 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S18 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S19 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S20 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S2 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S3 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S4 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S5 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S8 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S9 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L13 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L14 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L16 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L23 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S15 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L17 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L21 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L30 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L6 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S14 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S17 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S1 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L18 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L2 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L3 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L24 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L4 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L22 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L5 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S21 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L25 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L36 2 | Escherichia coli K-12 | 0.3 |
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Other Studies
2 other study(ies) available for l 694,458 and zithromax
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |